| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $48.0M | $36.5M | $28.7M |
| YoY Revenue Growth % | +31.4% | +27.0% | — |
| Gross Profit | $20.6M | $15.7M | — |
| Gross Margin % | 43.0% | 43.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$2.3M | -$3.6M | -$3.1M |
| Operating Margin % | -4.9% | -10.0% | -10.9% |
| Net Income (GAAP) | -$1.5M | -$3.2M | -$2.2M |
| EBITDA (Normalized) | -$1.9M | -$333.4K | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$1.0M | -$1.6M | -$11.2M |
| Capital Expenditures (CapEx) | $603.0K | $4.1M | — |
| Free Cash Flow (FCF) | -$1.6M | -$5.7M | -$11.2M |
| FCF Margin % | -3.3% | -15.7% | -39.0% |
| Return on Invested Capital (ROIC %) | -22.4% | -16.2% | — |
| Cash & Short-Term Equivalents | $7.2M | $5.1M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $15.4M | $22.8M | — |